Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
09 févr. 2022 07h23 HE
|
Lupin Ltd
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic...